Page results
-
Sonya Moudart has been appointed as a Mesothelioma UK Clinical Nurse Specialist at UCLH. In her new role, Sonya will provide care and support for mesothelioma (asbestos-related cancer) patients and in time, will be a beacon of expertise in all matters relating to mesothelioma for the North Central London Cancer Alliance area.
-
Charity Myeloma UK awards UCLH haematology team their Clinical Service Excellence Programme (CSEP) award in recognition of their outstanding care and unflagging dedication to patients living myeloma, an incurable blood cancer.
-
Minimally invasive therapies for prostate cancer which remove the cancer while leaving the rest of the prostate intact are beneficial for patients and cost effective according to new research.
-
A study has shed light on multiple factors in the recruitment process in research that act as barriers to the recruitment of patients from minority ethnic groups to trials.
-
University College Hospital's Outpatients department sees many patients, covering a variety of different specialties.
-
Read more about the award for researcher behind first treatment for rare disease
-
The Psychology Team are running the next group on Navigating the Exam Period on Wednesday 14 February 2024 from 1pm to 4pm at UCLH.
-
The Freedom of Information Act 2000 (FOIA) came into force on 1 January 2005 giving members of the public certain rights to ask public authorities for information relating to the public authority.
-
Information about the elected council of governors for UCLH - patient governors
-
Contact the UCLH Media and Communications team. Read the UCLH magazine.
File results
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311